A 68-year-old man with pernicious anemia (confirmed by low B12 and positive intrinsic factor antibody) has been receiving intramuscular cyanocobalamin 1000 mcg monthly for 6 months. His hemoglobin has normalized (Hb 13.5 g/dL), but he continues to report mild paresthesias in his feet. His MCV is now 88 fL. What is the most appropriate next step?

Question

Accepted Answer

A. Continue monthly B12 injections and refer to neurology for evaluation of persistent neurological symptoms. ## Dissociation Between Hematologic and Neurologic Recovery

**Key Point:** Hematologic recovery (normalization of Hb and MCV) does **not** guarantee neurological recovery. Neurological damage from **subacute combined degeneration (SCD)** may be **irreversible** if prolonged before treatment.

## Timeline of Recovery

| System | Recovery Timeline | Reversibility |
| --- | --- | --- |
| **Anemia** | 2–4 weeks (reticulocytosis); 2–3 months (Hb normalization) | Complete with adequate B12 |
| **Paresthesias** | Weeks to months | Often reversible if treated early |
| **Ataxia/Gait disturbance** | Months to years | Partially reversible; may be permanent if prolonged |
| **Spinal cord pathology** | Variable | Irreversible if demyelination is severe |

**Clinical Pearl:** Persistent paresthesias at 6 months of treatment suggest **established neurological damage** that may not fully resolve. Continued B12 supplementation is essential to prevent further deterioration.

## Management Strategy

**High-Yield:** In pernicious anemia with ongoing neurological symptoms:
  1. **Continue lifelong B12 supplementation** (monthly IM injections) — this is definitive therapy for pernicious anemia
  2. **Neurological evaluation** to document baseline deficits and assess for other causes (peripheral neuropathy, spinal cord MRI if indicated)
  3. **Expectation-setting:** Some neurological damage may be permanent; continued B12 prevents further deterioration

**Warning:** Do not discontinue B12 therapy even if anemia resolves — pernicious anemia requires lifelong replacement because the underlying autoimmune gastritis is permanent.

## Why Not the Other Options?

| Option | Reason |
| --- | --- |
| Discontinue B12 | Pernicious anemia requires **lifelong** B12 replacement; stopping will cause relapse of anemia and further neurological deterioration |
| Switch to oral B12 | Oral therapy is ineffective in pernicious anemia (intrinsic factor deficiency persists); parenteral route is mandatory |
| Increase frequency + folic acid | No evidence that higher B12 frequency improves established neurological damage; folic acid is not indicated (B12 is normal) |

[cite:Harrison 21e Ch 102]

Answer

B. Discontinue B12 injections as the anemia has resolved and monitor for relapse

Answer

C. Switch to oral cyanocobalamin 2000 mcg daily to improve neurological outcomes

Answer

D. Increase B12 injection frequency to weekly and add high-dose folic acid supplementation

Explanation

Dissociation Between Hematologic and Neurologic Recovery

Timeline of Recovery

Management Strategy

Why Not the Other Options?

Practice similar questions

Join our NEET PG community

System	Recovery Timeline	Reversibility
Anemia	2–4 weeks (reticulocytosis); 2–3 months (Hb normalization)	Complete with adequate B12
Paresthesias	Weeks to months	Often reversible if treated early
Ataxia/Gait disturbance	Months to years	Partially reversible; may be permanent if prolonged
Spinal cord pathology	Variable	Irreversible if demyelination is severe

Option	Reason
Discontinue B12	Pernicious anemia requires lifelong B12 replacement; stopping will cause relapse of anemia and further neurological deterioration
Switch to oral B12	Oral therapy is ineffective in pernicious anemia (intrinsic factor deficiency persists); parenteral route is mandatory
Increase frequency + folic acid	No evidence that higher B12 frequency improves established neurological damage; folic acid is not indicated (B12 is normal)